ID: ALA436093

Max Phase: Preclinical

Molecular Formula: C7H18N2O2S

Molecular Weight: 194.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)NCCCCCCN

Standard InChI:  InChI=1S/C7H18N2O2S/c1-12(10,11)9-7-5-3-2-4-6-8/h9H,2-8H2,1H3

Standard InChI Key:  BETXAVQKYPPAKQ-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 194.30Molecular Weight (Monoisotopic): 194.1089AlogP: 0.05#Rotatable Bonds: 7
Polar Surface Area: 72.19Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.09CX Basic pKa: 10.20CX LogP: -0.74CX LogD: -3.25
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.56Np Likeness Score: -0.78

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source